Cite
HARVARD Citation
Hopkins, P. et al. (2015). Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circulation. p. . [Online].